Colleagues and future collaborators:

I seek to work with integrity and humanity with patients, colleagues, and teams across borders and fields.

I advise on the intersection of AI with human cognition as well as with psychosis, addiction, and behavioral patterns that determine whether individuals flounder or flourish.

I'm a "Double doc" (MD/PhD) with US Medical Board Certifications in Lifestyle Medicine, Psychiatry, and Addiction Medicine and a PhD in neuroscience. I've cared for more than 6000 patients on three continents.

Through the Oxford Alumni Angel and Venture Funds and strategic advisor work, I support early stage companies making a difference in industries ranging from textiles to fentanyl detection.

I am involved with the Harvard Global Mental Health Trauma and Recovery Program and serve peers via physician wellbeing work, disability consultancy, and quality assessment.

Publications spanning the neuroscience of schizophrenia to global HIV followed my work with the NIH, several US universities, the Prince of Wales International Centre at Oxford University, the Kenya Medical Research Institute, the South African AIDS Vaccine Initiative, and the Centre for Infectious Disease Research in Zambia.

Specifically, I was honored to work alongside superb colleagues to study psychosis and neurodevelopment from ages 16 to 18 in British youth, and whether viral load monitoring conferred a survival benefit (yes) among 2000 people living with HIV across 12 health centres in Zambia. This informed global HIV treatment guidelines.